Silence Therapeutics (SLN)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

 530.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 649.00
  • 52 Week Low: 339.00
  • Currency: UK Pounds
  • Shares Issued: 89.74m
  • Volume: 17,107
  • Market Cap: 475.60m
  • RiskGrade: 177

SLN Overview

Silence Therapeutics is in the pharma and biotech sector and is currently trading at 530.00p per share. In the last year Silence Therapeutics's share price has ranged from 339.00p to 649.00p and brokers are currently rating this stock as 'strong buy'.

1 Day Chart (22-09-2021)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -654.2% -301.8%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 86.8 37.4
Pr/Book 52.5  
Latest F'cast
Revenue 2183.3% 138.0%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

SLN Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-16 0.77 (10.36) (12.10)p n/a n/a n/a n/a 0.0%
31-Dec-17 0.02 (3.77) (2.30)p n/a n/a n/a n/a 0.0%
31-Dec-18 n/a (20.53) (26.20)p n/a n/a n/a n/a 0.0%
31-Dec-19 0.24 (22.87) (26.10)p n/a n/a n/a n/a 0.0%
31-Dec-20 5.48 (36.04) (39.80)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

SLN Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 13.04 (39.37) (32.72)p n/a n/a n/a n/a 0.0%
31-Dec-22 24.98 (42.45) (28.88)p n/a n/a n/a n/a 0.0%

Copyright © 2021 FactSet Research Systems Inc. All rights reserved.

SLN Company Announcements

Holding(s) in Company 08-Sep-2021 16:03 RNS
Holding(s) in Company 08-Sep-2021 16:00 RNS
Silence Appoints Senior VP of BD, AM and NPD. 01-Sep-2021 07:00 RNS

Latest SLN Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

SLN Market Data

Currency UK Pounds
Share Price 530.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 649.00
52 Week Low 339.00
Volume 17,107
Shares Issued 89.74m
Market Cap 475.60m
RiskGrade 177

SLN Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
43.31% below the market average43.31% below the market average43.31% below the market average43.31% below the market average43.31% below the market average
48% below the sector average48% below the sector average48% below the sector average48% below the sector average48% below the sector average
Price Trend
15.37% above the market average15.37% above the market average15.37% above the market average15.37% above the market average15.37% above the market average
29.03% above the sector average29.03% above the sector average29.03% above the sector average29.03% above the sector average29.03% above the sector average
Income Not Available
Growth
25.80% above the market average25.80% above the market average25.80% above the market average25.80% above the market average25.80% above the market average
22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 5
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

SLN Dividends

No dividends found

Trades for 22-Sep-2021

Time Volume / Share Price
16:35 4,714 @ 530.00p
16:28 31 @ 531.00p
16:28 32 @ 535.00p
16:25 47 @ 531.00p
16:25 35 @ 536.00p

Top of Page